Name | KWCN-41 |
---|
Description | KWCN-41 is a selective and efficient inhibitor of RIPK1 kinase with an IC50 value of 88 nM. KWCN-41 specifically inhibits cell necrosis but does not inhibit apoptosis. KWCN-41 also has anti-inflammatory effects[1]. |
---|---|
Related Catalog | |
Target |
IC50: 88 nM (RIP Kinase)[1] |
In Vitro | KWCN-41(10, 50, 250 nM; 1 h)以剂量依赖性方式抑制 L929 细胞坏死,并增加活细胞区的细胞数量[1]。 KWCN-41(10、50、250 nM;0.5、1.5、2.5 h)抑制 L929 细胞中 RIPK1/3 和 MLKL 的磷酸化[1]。 KWCN-41 (0-10 μM) 以剂量依赖性方式抑制 TZ 诱导的 L929 细胞坏死,并类似地保护细胞免受 TSZ(TNF-α、Smac 模拟物和 z-VAD-FMK)诱导的 HT- 29 和 U937 细胞[1]。 Cell Viability Assay[1] Cell Line: L929 cells Concentration: 10, 50, 250 nM Incubation Time: 1 h Result: Inhibited L929 cell necroptosis in a Dosedependent manner and increased the number of cells in the viable cell zone. |
In Vivo | KWCN-41(10、25、40 mg/kg;腹腔注射;72 小时)在 25、40 mg/kg 时完全抑制 TNF-α 诱导的小鼠死亡,实现 100% 的存活率,而在 10 mg/kg 时,小鼠存活率为 75%[1]。 Animal Model: Inflammatory mouse model[1] Dosage: 10, 25, 40 mg/kg Administration: i.p.; dissolved in saline containing 10% DMSO and 20% Tween80; 72 h Result: At 25, 40 mg/kg completely inhibited TNF-α induced death in mice, achieving 100% survival compared to 75% survival at 10 mg/kg. |
References |
Molecular Formula | C18H17N3O2 |
---|---|
Molecular Weight | 307.35 |